Journal
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Volume 59, Issue 10, Pages 1210-1217Publisher
WILEY
DOI: 10.1111/j.1368-5031.2005.00660.x
Keywords
non-steroidal anti-inflammatory drugs; gastrointestinal toxicity; proton pump inhibitors; pantoprazole; prophylaxis
Ask authors/readers for more resources
Non-steroidal anti-inflammatory drugs (NSAIDs) are associated with gastrointestinal adverse effects, ranging from dyspepsia and peptic ulcer disease to more serious complications such as haemorrhage or perforation. NSAID-induced gastrointestinal toxicity is a significant medical problem worldwide. Misoprostol is effective in reducing NSAID-induced mucosal damage, but patient compliance is limited by poor tolerance. Histamine receptor antagonists are relatively effective against duodenal ulcers but offer no significant protection against gastric ulcers. Proton pump inhibitors (PPIs), such as pantoprazole, omeprazole and lansoprazole, have been shown to be effective in preventing the development of gastric and duodenal ulcers in high-risk patients taking NSAIDs. PPI therapy is also beneficial in healing NSAID-induced ulcers and preventing their recurrence in patients requiring ongoing NSAID therapy. PPIs have an excellent safety profile, and pantoprazole - with its low potential for drug-drug interactions - is particularly suitable for administration to elderly patients who often require concomitant treatment with other medications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available